NW
ONC

NewEdge Wealth’s BeOne Medicines Ltd ONC Stock Holding History

NewEdge Wealth’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$523K Buy
1,834
+7
+0.4% +$2.06K 0.01% 845
2026
Q1 		$543K Sell
1,827
-27
-1% -$8.74K 0.01% 790
2025
Q4 		$563K Sell
1,854
-23
-1% -$7.53K 0.01% 797
2025
Q3 		$603K Buy
1,877
+123
+7% +$37.4K 0.01% 697
2025
Q2 		$523K Buy
1,754
+71
+4% +$17.4K 0.01% 701
2025
Q1 		$458K Buy
1,683
+20
+1% +$4.68K 0.01% 676
2024
Q4 		$307K Sell
1,663
-5
-0.3% -$1.02K 0.01% 760
2024
Q3 		$374K Sell
1,668
-1,348
-45% -$243K 0.01% 675
2024
Q2 		$430K Sell
3,016
-71
-2% -$10.9K 0.01% 580
2024
Q1 		$500K Buy
3,087
+1,475
+92% +$238K 0.01% 562
2023
Q4 		$291K Buy
1,612
+112
+7% +$20.3K 0.01% 628
2023
Q3 		$270K Sell
1,500
-587
-28% -$116K 0.01% 564
2023
Q2 		$372K Buy
2,087
+26
+1% +$5.99K 0.01% 508
2023
Q1 		$444K Sell
2,061
-55
-3% -$13.2K 0.02% 431
2022
Q4 		$465K Buy
2,116
+55
+3% +$10.1K 0.02% 378
2022
Q3 		$278K Buy
2,061
+264
+15% +$45.3K 0.01% 441
2022
Q2 		$291K Buy
+1,797
New +$281K 0.01% 469

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NewEdge Wealth's ONC Position: Q2 2026 in Review

NewEdge Wealth increased its BeOne Medicines Ltd (ONC) stake by 0.38% in Q2 2026, buying an estimated $2.06K and bringing the position to 1,834 shares worth $523K. The position accounts for 0.01% of the portfolio, ranked #845.

NewEdge Wealth first reported a position in ONC in Q2 2022 and has held it in 17 quarters since. The position peaked at $603K in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • NewEdge Wealth held 1,834 shares of BeOne Medicines Ltd worth $523K as of Q2 2026.
  • NewEdge Wealth bought 7 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.06K.
  • BeOne Medicines Ltd made up 0.01% of NewEdge Wealth's portfolio in Q2 2026, its #845 holding.
  • NewEdge Wealth first reported a position in BeOne Medicines Ltd in Q2 2022 and has held it in 17 quarters since.
  • NewEdge Wealth's BeOne Medicines Ltd position peaked at $603K in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.